Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the pediatric vaccine market right now?

The magnitude of the pediatric vaccine market has swiftly expanded in the past years. It is projected to surge from $45.9 billion in 2024 to $51.56 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.3%. The historical period growth is due to higher incidences of chronic ailments, implementation of immunization rules to eliminate widespread diseases, and escalation in funding for the advancement of vaccines.

How fast Is the pediatric vaccine market expected to grow, and what’s its future value?

The anticipated expansion for the medical coding market size is quite substantial, with predictions showing a surge to $29.2 billion by 2029. This rise, translating to a compound annual growth rate (CAGR) of 11.1%, can be credited to multiple factors. Significant among these are advancements in workforce education and up-skilling, the broadening scope of the global healthcare market, regulatory modifications and compliance requirements, as well as the proliferation of telehealth and remote medical services. Furthermore, the shift to value-focused care models will also influence growth during the forecast period. Key trends that will emerge during this forecast period include investing in education and advanced training programs, adopting remote and outsourced operations, ensuring EHR integration and interoperability, demand surge in specialized coding, and an increased emphasis on precision and quality.

Get your pediatric vaccine market report here!

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

What are the leading drivers of growth in the pediatric vaccine market?

The surge in chronic illnesses like tuberculosis, diphtheria, and pneumonia among individuals aged 15 years and below is contributing to the expansion of the pediatric vaccines market. Children and teenagers with chronic ailments are facing an escalating risk of severe disease outcomes and complications from infectious diseases. The Australian Bureau of Statistics noted in March 2022 that approximately half of the total population (46.6%, which equates to 11.6 million people) had one or more chronic conditions. This escalating prevalence of chronic diseases in children is boosting the need for immunization against these illnesses, thereby fueling the growth of the pediatric vaccine market.

What are the key segments defining the pediatric vaccine market?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Who are the key players steering the development of the pediatric vaccine market?

Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

What emerging trends are influencing the growth of the pediatric vaccine market?

The demand for innovative vaccines is consistently on the rise in order to provide enhanced protection against difficult-to-treat infectious diseases (e.g., tuberculosis, HIV/AIDS) and chronic non-infectious diseases like cancer and neurodegenerative diseases. Vaccine development is being revolutionized by novel approaches such as structural immunogenic design, gene-based vaccine platforms, and potent adjuvant recombinant antigen formulations. In response to the escalating demand for innovative vaccines, pediatric vaccine manufacturers and developers are persistently pursuing advancements in vaccine design and production technologies. For example, in April 2023, Pfizer Inc., a pharmaceutical manufacture based in the US, announced that the U.S. FDA had approved their 20-valent Pneumococcal Conjugate Vaccine for children and infants known as REVNAR 20.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2824

Which regions are most influential in expanding the pediatric vaccine market?

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Anesthesia Disposables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Hearing Aid Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hearing-aid-devices-and-equipment-global-market-report

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: